Cadre Holdings, Inc. (CDRE) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary indicates positive financial performance with record-high adjusted EBITDA and improved gross margins. Despite some revenue timing issues, the company's backlog growth and strong visibility on large opportunities are promising. The Q&A section reveals confidence in delayed contracts and growth in commercial nuclear opportunities, although management was vague on some details. The TYR acquisition and blast seat contracts are expected to contribute positively in the future. Given the strong financial metrics, optimistic guidance, and market cap, the stock price is likely to experience a positive movement.
Key Financial Performance
Orders backlog Orders backlog was up significantly, with a nearly 50% increase compared to last year. This growth was driven by 2025 order growth and the addition of Carr's Engineering division in April. The backlog includes a $50 million IDIQ contract for the Blast Exposure Monitoring System (BEMO), a major achievement for the company.
Consumer channel growth The consumer channel saw a 7% growth for the full year and a 15% growth in the second half of 2025 compared to the prior year. This growth was attributed to the strength of the Safariland brand and new product introductions.
Med-Eng contracts Med-Eng was awarded $86 million in contracts by General Dynamics European Land Systems (GDELS) to provide blast attenuation seats. These contracts highlight the company's expertise in blast physics and product development capabilities. Production and delivery are scheduled to begin in 2026 and continue until 2031 for one contract, and until 2029 for the other.
Adjusted EBITDA Adjusted EBITDA for 2025 was $111.7 million, marking a record for the third consecutive year. This represents significant year-over-year growth and reflects improved gross margins, which increased by 140 basis points.
Public safety product gross margins Gross margins for public safety products (excluding distribution and nuclear) increased by 188 basis points for the full year 2025. This improvement was attributed to strong execution by the teams.
Net sales Net sales for the full year 2025 increased significantly year-over-year. However, fourth-quarter top and bottom-line results were down compared to last year's record Q4. Revenue timing shifts in nuclear businesses and EOD product lines, distribution softness, and a slight impact from the government shutdown contributed to the decline.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Blast Exposure Monitoring System (BEMO): Secured a $50 million IDIQ contract with the U.S. military, marking a significant achievement.
Med-Eng Blast Attenuation Seats: Awarded $86 million in contracts by General Dynamics European Land Systems for life-saving seats, with production starting in 2026.
TYR Tactical Acquisition: Acquired TYR Tactical, enhancing capabilities in hard armor and opening access to international markets.
Geographic Expansion: Secured large opportunities in South America, Eastern and Western Europe, UAE, and parts of Asia.
Nuclear Market Growth: Strong opportunities in nuclear ventilation, containment systems, and criticality alarm systems driven by expanded government and commercial programs.
Backlog Growth: Backlog increased nearly 50% year-over-year, driven by acquisitions and contract wins.
Integration Efforts: Focused on aligning leadership, sharing engineering capabilities, and strengthening market approaches across acquired businesses.
M&A Strategy: Maintains an active pipeline for acquisitions in public safety and nuclear markets, focusing on high-margin, growth-oriented businesses.
Financial Discipline: Strong balance sheet supports investments in organic growth and acquisitions while returning capital to shareholders.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Large Opportunities Visibility: Challenges around visibility of closing and booking larger opportunities, which could impact revenue recognition and financial planning.
Nuclear Material Movement: Slowed plutonium material movement due to shifts in priorities at nuclear sites, impacting financial performance in the nuclear segment.
Revenue Timing Shifts: Revenue timing shifts in nuclear businesses and EOD product lines, leading to potential short-term financial impacts.
Distribution Softness: Softness in distribution revenue, which could affect overall financial performance.
Government Shutdown Impact: Slight impact on chemical luminescence product revenue due to the government shutdown.
Integration Challenges: Ongoing integration of acquisitions like TYR Tactical, which requires significant resources and alignment to unlock synergies.
Material Constraints: Armor material constraints affecting project timing and revenue realization.
Economic and Geopolitical Cycles: Potential uncertainties due to economic, political, and geopolitical cycles, which could impact demand and operations.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue and Adjusted EBITDA Growth: For 2026, Cadre expects net sales between $736 million and $758 million, and adjusted EBITDA between $136 million and $141 million, implying adjusted EBITDA margins of 18.5%. Organic growth for public safety and nuclear businesses is projected at 3% to 5%, with a 1% price increase net of material inflation.
Quarterly Revenue Cadence: Revenue is expected to be heavier in the second half of 2026, with a lighter Q1. Q1 revenue is projected to be similar to Q3 2025, with margins around 39% due to volume and mix. EBITDA margins in Q1 are expected to be in the low teens.
Public Safety and Nuclear Business Outlook: Continued strong demand is expected in 2026 across core markets in public safety and nuclear safety. The nuclear business faces near-term headwinds in one segment, but the broader outlook remains positive with commercial nuclear opportunities expected to improve mix over time.
Blast Sensor and Blast Attenuation Seat Contracts: Two significant contracts, including a blast sensor order and blast attenuation seat contracts, are expected to contribute to multiyear revenue growth starting in 2026.
M&A Strategy and Integration: Cadre plans additional M&A in 2026, focusing on high-quality, strategically aligned businesses. The integration of TYR Tactical is underway, with initial projects leveraging TYR's capabilities to enhance Cadre's product offerings.
Market Trends and Demand Drivers: Rising global safety threats and growing defense budgets are expected to drive demand in law enforcement and public safety markets. In the nuclear sector, expanded government and commercial programs are creating growth opportunities, particularly in nuclear ventilation, containment systems, and criticality alarm systems.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Quarterly Dividends: Cadre has paid 17 consecutive quarterly dividends since going public.
Dividend Increase: Recently raised the dividend to $0.40 per share on an annualized basis.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What is the visibility on large opportunities and backlog growth?
A:The company has good visibility on large opportunities, many of which are now in the backlog. Some orders were delayed but are now secured, such as the blast seats and sensor program. There are other large opportunities funded but not yet booked due to various details.
Q:What is the impact of the shift in nuclear prioritization on revenue and margins?
A:The shift from plutonium cleanup to plutonium build-out has caused a timing lag in revenue and a mix change impacting margins. Down blending, which has higher margins, is being replaced by commercial nuclear projects, which are growing in the funnel and expected to drive long-term growth.
Q:What is the margin outlook for the coming year?
A:The margin outlook is slightly up but mostly flat, primarily due to the mix impact in the nuclear segment.
Q:What gives confidence that delayed contracts are not lost?
A:Management has 100% confidence that the delayed contracts are not lost, citing strong visibility and specific awarded orders in the pipeline.
Q:What is the reason for the increase in CapEx guidance for 2026?
A:The increase in CapEx to $10 million to $14 million is primarily for capacity expansion in the nuclear area, including site build-outs.
Q:What is the revenue contribution and EBITDA margin outlook for TYR?
A:TYR is expected to contribute about $100 million annually, with $80-$90 million baked into 2026 guidance due to the February acquisition. EBITDA margins are expected to be around 20%.
Q:How will the blast seat contract ramp up and contribute to revenue?
A:The blast seat contract will begin production planning in 2026, with most revenue contribution expected in 2027 and beyond.
Q:What is the outlook for down blending and related opportunities?
A:Down blending funding has decreased due to an executive order, shifting focus to pit production programs and commercial nuclear opportunities. The company is pursuing opportunities in nuclear ventilation, containment systems, and criticality alarm systems.
Q:What are the details of the General Dynamics blast seat contract?
A:The contract involves blast attenuation seats for combat vehicles, with a proven track record of saving lives. The company has extensive experience in this category and expects potential follow-on orders.
Q:What synergies are expected from the TYR acquisition?
A:No synergies are built into the guidance. However, two projects have been initiated to explore TYR's capabilities within the Armor and Med-Eng business units.
Q:What is the Q1 2026 revenue and margin outlook?
A:Q1 revenue is expected to be around $155.8 million, with gross margins at 39% and EBITDA margins in the low teens. Some transaction costs will carry over into Q1.
Q:What is driving the organic backlog decline?
A:The decline is due to large shipments in Q4, including international wins and duty gear orders. However, year-over-year backlog is still significantly up.
Q:What gives confidence in commercial nuclear opportunities?
A:The company has a strong track record in ventilation containment and criticality alarm systems, with a growing number of opportunities in these areas.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on certain large opportunities and delayed contracts, citing competitive reasons. They also did not elaborate on the exact synergies expected from the TYR acquisition or the specific projects initiated with TYR.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Armor
Med Eng
Safariland
TYR Tactical
TYR acquisition
TYR armor
TYR customer
acquisition TYR
beginning
blast attenuation
blast sensor
business demand
capability business
capability market
core market
criterion
criticality
customer relationship
demand core
development
distribution
duty gear
engineering capability
expertise
introduction
market safety
market segment
mission safety
opportunity TYR
past
platform capability
plutonium
portfolio business
product line
production
safety business
seat
site
solution
technology
trust
win
CDRE Transcript
Cadre Holdings, Inc. (CDRE) Q4 2025 Earnings Call Transcript
Positive3-11
The earnings call summary indicates positive financial performance with record-high adjusted EBITDA and improved gross margins. Despite some revenue timing issues, the company's backlog growth and strong visibility on large opportunities are promising. The Q&A section reveals confidence in delayed contracts and growth in commercial nuclear opportunities, although management was vague on some details. The TYR acquisition and blast seat contracts are expected to contribute positively in the future. Given the strong financial metrics, optimistic guidance, and market cap, the stock price is likely to experience a positive movement.
Cadre Holdings, Inc. (CDRE) Q3 2025 Earnings Call Transcript
Positive11-5
The earnings call highlights strong financial performance with a 42% YoY sales increase and improved margins. The company maintains financial flexibility and continues to pay dividends. The Q&A section addresses concerns well, with positive sentiment from analysts. The TYR acquisition, while presenting integration risks, is expected to be accretive. Despite macroeconomic uncertainties, the company's strategic positioning in high-demand sectors like nuclear and defense is promising. Overall, the sentiment is positive, with potential for a stock price increase of 2% to 8% over the next two weeks, considering the company's market cap.
Cadre Holdings, Inc. (CDRE) Q2 2025 Earnings Call Transcript
Positive8-7
The earnings call summary highlights strong financial performance, improved EBITDA, and strategic acquisitions. The Q&A section reveals positive analyst sentiment, with management addressing concerns effectively. The guidance remains optimistic, with opportunities for margin improvement and growth in defense and nuclear sectors. The dividend increase and successful integration of acquisitions further support a positive outlook. Despite some order pushouts, the overall sentiment is positive, with management demonstrating confidence in future growth and ability to manage risks like tariffs.
Earnings call transcript: Cadre Holdings Q1 2025 beats expectations, stock surges
Positive5-7
Cadre's earnings call reveals a positive outlook with strong financial performance, including above-expectation Q1 sales and EBITDA, improved margins, and a significant dividend increase. Despite challenges like tariffs and economic uncertainty, management has strategies to offset these risks. The acquisition expands geographic reach, and the company maintains strong financial flexibility. The Q&A session indicates confidence in overcoming tariff impacts and growing demand in the nuclear sector. Given the company's small-cap status, the stock price is likely to react positively, with a predicted increase of 2% to 8% over the next two weeks.
CDRE Slides
CDRE Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
